A microbiome is the collective genomes of the microorganisms that reside in an environmental niche. The term "microbiome" was coined by Joshua Lederberg, who argued that microorganisms inhabiting the human body should be included as part of the human genome, because of their influence on human physiology. Some consider it to be a "newly discovered organ" since its existence was not generally recognized until the late 1990s and it is understood to potentially have overwhelming impact on human health. Modern DNA testing of their residues has enabled researchers to find the majority of these microbes, since the majority of them cannot be cultured in a lab using current techniques.
Its most important aspect may be its possible effect on auto-immune diseases like diabetes, rheumatoid arthritis, muscular dystrophy, multiple sclerosis, fibromyalgia, and perhaps some cancers. In this half-day symposium, leading experts studying these various connections to health and disease will share their findings and discuss possible opportunities for collaborations.
1:00 Karen Nelson, Craig Venter Institute
"Results of the Human Microbiome Project"
2:00 Larry Smarr, UCSD/Calit2
"Interactions of the Immune System with the Gut Microbiome in
Inflammatory Bowel Disease"
2:40 Huiying Li, UCLA
"The Human Skin Microbiome in Acne at the Strain Level"
3:20 Manuela Raffatellu, UCI
"Colonization of the Inflamed Gut: Why a Subset of Gut Bacteria Thrives"
4:00 Nick Vaziri, UCI
"Chronic Kidney Disease Alters the Composition of the Intestinal
Microbiome and Disrupts Intestinal Barrier Structure and Function"
4:40 David Underhill, Cedars-Sinai
"Fungal Microbiomes in Health and Disease"
5:30 Wine and cheese reception in Calit2 Building Atrium